rapid micro biosystems inc - RPID

RPID

Close Chg Chg %
2.13 0.06 2.82%

Closed Market

2.19

+0.06 (2.82%)

Volume: 225.05K

Last Updated:

Apr 14, 2026, 4:00 PM EDT

Company Overview: rapid micro biosystems inc - RPID

RPID Key Data

Open

$2.14

Day Range

2.13 - 2.21

52 Week Range

2.00 - 4.94

Market Cap

$96.84M

Shares Outstanding

45.46M

Public Float

20.84M

Beta

1.60

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.06

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

237.47K

 

RPID Performance

1 Week
 
3.30%
 
1 Month
 
-22.61%
 
3 Months
 
-47.61%
 
1 Year
 
-8.75%
 
5 Years
 
N/A
 

RPID Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4
Full Ratings ➔

About rapid micro biosystems inc - RPID

Rapid Micro Biosystems, Inc. is a life sciences technology company. It provides automated solutions to facilitate the efficient manufacturing and safe release of healthcare products such as biologics, vaccines, cell & gene therapies, and sterile injectable. The company was founded by Donald Straus on December 29, 2006 and is headquartered in Lexington, MA.

RPID At a Glance

Rapid Micro Biosystems, Inc.
25 Hartwell Avenue
Lexington, Massachusetts 02421
Phone 1-978-349-3200 Revenue 33.59M
Industry Industrial Machinery Net Income -47,123,000.00
Sector Producer Manufacturing 2025 Sales Growth 19.735%
Fiscal Year-end 12 / 2026 Employees 171
View SEC Filings

RPID Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 3.858
Price to Book Ratio 3.884
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -2.609
Enterprise Value to Sales 3.428
Total Debt to Enterprise Value 0.207

RPID Efficiency

Revenue/Employee 196,415.205
Income Per Employee -275,573.099
Receivables Turnover 10.246
Total Asset Turnover 0.388

RPID Liquidity

Current Ratio 3.309
Quick Ratio 2.357
Cash Ratio 2.072

RPID Profitability

Gross Margin 3.117
Operating Margin -141.102
Pretax Margin -140.182
Net Margin -140.301
Return on Assets -54.471
Return on Equity -86.816
Return on Total Capital -82.556
Return on Invested Capital -69.254

RPID Capital Structure

Total Debt to Total Equity 71.897
Total Debt to Total Capital 41.826
Total Debt to Total Assets 31.895
Long-Term Debt to Equity 67.988
Long-Term Debt to Total Capital 39.552
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Rapid Micro Biosystems Inc - RPID

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
17.13M 22.52M 28.05M 33.59M
Sales Growth
-26.25% +31.44% +24.57% +19.74%
Cost of Goods Sold (COGS) incl D&A
25.67M 28.00M 28.16M 32.54M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
3.98M 3.10M 3.36M 3.25M
Depreciation
3.68M 2.81M 2.96M 2.75M
Amortization of Intangibles
300.00K 300.00K 400.00K 500.00K
COGS Growth
-17.11% +9.08% +0.56% +15.55%
Gross Income
(8.54M) (5.49M) (109.00K) 1.05M
Gross Income Growth
-10.32% +35.77% +98.01% +1,060.55%
Gross Profit Margin
-49.85% -24.36% -0.39% +3.12%
2022 2023 2024 2025 5-year trend
SG&A Expense
54.68M 51.08M 49.81M 48.44M
Research & Development
12.87M 12.82M 14.60M 13.60M
Other SG&A
41.81M 38.26M 35.21M 34.84M
SGA Growth
+38.46% -6.59% -2.48% -2.75%
Other Operating Expense
- - - -
-
Unusual Expense
- - - (131.00K)
-
EBIT after Unusual Expense
(63.22M) (56.56M) (49.92M) (47.26M)
Non Operating Income/Expense
1.84M 4.13M 3.05M 1.27M
Non-Operating Interest Income
1.78M 4.21M 3.16M 1.51M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 1.09M
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - 1.09M
-
Interest Capitalized
- - - -
-
Pretax Income
(61.38M) (52.44M) (46.87M) (47.08M)
Pretax Income Growth
+16.41% +14.57% +10.62% -0.46%
Pretax Margin
-358.27% -232.85% -167.08% -140.18%
Income Tax
(576.00K) 31.00K 22.00K 40.00K
Income Tax - Current - Domestic
16.17M 12.42M 11.49M 11.42M
Income Tax - Current - Foreign
(576.00K) 31.00K 22.00K 40.00K
Income Tax - Deferred - Domestic
(16.17M) (12.42M) (11.49M) (11.42M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(60.81M) (52.47M) (46.89M) (47.12M)
Minority Interest Expense
- - - -
-
Net Income
(60.81M) (52.47M) (46.89M) (47.12M)
Net Income Growth
+17.30% +13.71% +10.63% -0.50%
Net Margin Growth
-354.91% -232.99% -167.16% -140.30%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(60.81M) (52.47M) (46.89M) (47.12M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(60.81M) (52.47M) (46.89M) (47.12M)
EPS (Basic)
-1.4323 -1.2195 -1.076 -1.0547
EPS (Basic) Growth
+23.89% +14.86% +11.77% +1.98%
Basic Shares Outstanding
42.45M 43.02M 43.58M 44.68M
EPS (Diluted)
-1.4323 -1.2195 -1.076 -1.0547
EPS (Diluted) Growth
+23.89% +14.86% +11.77% +1.98%
Diluted Shares Outstanding
42.45M 43.02M 43.58M 44.68M
EBITDA
(59.24M) (53.46M) (46.56M) (44.14M)
EBITDA Growth
-29.90% +9.76% +12.91% +5.19%
EBITDA Margin
-345.76% -237.39% -165.97% -131.42%

Snapshot

Average Recommendation BUY Average Target Price 8.00
Number of Ratings 4 Current Quarters Estimate -0.233
FY Report Date 06 / 2026 Current Year's Estimate -0.923
Last Quarter’s Earnings -0.25 Median PE on CY Estimate N/A
Year Ago Earnings -1.05 Next Fiscal Year Estimate -0.823
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 3 3
Mean Estimate -0.23 -0.22 -0.92 -0.82
High Estimates -0.20 -0.21 -0.89 -0.74
Low Estimate -0.26 -0.23 -0.96 -0.91
Coefficient of Variance -13.09 -4.55 -3.80 -10.33

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 4 4
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Rapid Micro Biosystems Inc in the News